[1] |
Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of Ticagrelor versus Clopidogrel in patients with stable coronary artery disease[J].Circulation.2009,120(25): 2577-2585.
|
[2] |
Yundai Chen, Wei Dong, Zheng Wan,et al.Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome: A Pharmacodynamic Analysis[J].Int J Cardiol. 2015,15;201:545-546.
|
[3] |
Gurbel PA, Bliden KP, Butler K, et al.Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study[J].Circulation.2010,16;121(10):1188-1199.
|
[4] |
Alexopoulos D1, Galati A, Xanthopoulou I,et al.Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study[J].J Am Coll Cardiol.2012,17;60(3):193-199.
|
[5] |
李慕鹏,熊艳,陈小平.抗血小板药物替格瑞洛药代药效动力学及遗传药理学研究进展[J]..中国临床药理学与治疗学.2014,19(2):214-222.
|
[6] |
Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med.2009,361(11): 1045-1057.
|
[7] |
Steg PG, James S, Harrington RA, et al. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis[J]..Circulation. 2010,23;122(21):2131-2141.
|
[8] |
Matthijs A Velders, Jérémie Abtan, Dominick J Angiolillo,et al.Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention[J].Heart.2016,102(8):617-625.
|
[9] |
Vercellino M, Sànchez FA, Boasi V,et al.Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction:1-year results by propensity score analysis[J].BMC Cardiovasc Disord.2017,5;17(1):97.
|
[10] |
周登峰,石焱.氯吡格雷及替格瑞洛治疗急性冠状动脉综合征1年临床疗效对比[J].中国临床医学.2016,23(3):291-294.
|
[11] |
许骥,华琦,胡少东,等.替格瑞洛在老年STEMI患者急诊PCI中的疗效与安全性分析[J].首都医科大学学报,2015,36(1):73-77.
|
[12] |
阙斌,聂绍平,王春梅,等.替格瑞洛在老年心肌梗死急诊冠状动脉介入治疗中的作用研究[J].中华老年心脑血管病杂志.2015,17(10):1013-1016.
|
[13] |
Yang J, Zeng P, Cai WY,et al.Comparison of treatment outcomes of ticagrelor and clopidogrel among patients undergoing percutaneous coronary intervention: A meta-analysis[J].J Huazhong Univ Sci Technolog Med Sci.2017,37(5):675-680.
|
[14] |
Daniel Lindholm, Christoph Varenhorst, Christopher P Cannon,et al.Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial[J].European Heart Journal.2014,35:2083-2093.
|
[15] |
Cannon CP, Husted S, Harrington RA,et al.Safety,tolerability,and initial efficacy of AZD6140,the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndromes primary results of the DISPERSE2 trial[J].J Am Coll Cardiol.2007,50(19):1844-1851.
|
[16] |
Bavishi C, Panwar S, Messerli FH,et al.Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors(Prasugrel or?Ticagrelor) to?Clopidogrel?in?Patients?With?Non-ST-Elevation Acute Coronary Syndrome[J].Am J Cardiol. 2015,1;116(5):809-17.
|
[17] |
Alexopoulos D, Despotopoulos S, Xanthopoulou I,et al.Low-Dose Ticagrelor Versus Clopidogrel in Patients With Prior Myocardial Infarction[J].J Am Coll Cardiol. 2017,70(16):2091-2092.
|
[18] |
Li P, Gu Y, Yang Y,et al.Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial[J].Sci Rep.2016,6:31838.
|
[19] |
Bonaca MP, Bhatt DL, Cohen M,et al.Long-term use of ticagrelor in patients with prior myocardial infarction[J].N Engl J Med.2015 May 7;372(19):1791-800.
|
[20] |
Albert Yuh-Jer Shen, Janis F. Yao,Somjot S. Brar,et al.Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation.Journal of the American College of Cardiology[J].J Am Coll Cardiol. 2007,50(4):309-315.
|
[21] |
Ma C.Current antithrombotic treatment in East Asia:some perspectives on anticoagulation and antiplatelet therapy[J].Thromb Haemost.2012,107(6):1014-1018.
|
[22] |
《老年人心房颤动诊治中国专家建议》写作组,中华医学会老年医学分会,中华老年医学杂志编辑委员会.老年人非瓣膜性心房颤动诊治中国专家建议(2016).中华老年医学杂志.2016,35(9):915-928.
|
[23] |
Young-Hoon Jeong. "East asian paradox" :challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome[J]. Curr. Cardiol. Rep. 2014,16(5):485.
|
[24] |
Goto S, Toda E.Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention[J]. Hamostaseologie. 2009,29(4):321-325.
|
[25] |
Goto S, Huang CH, Park SJ,et al.Ticagrelor vs.clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome-- randomized,double-blind,phase III PHILO study[J].Circ J.2015,75(11):2452-2460.
|
[26] |
Keun-Ho Park, Myung Ho Jeong b, Youngkeun Ahn,et al.Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization;from Korea Acute Myocardial Infarction Registry-National Institute of Health[J].Int J Cardiol.2016,215:193-200.
|
[27] |
Glenn N. Levine, Young-Hoon Jeong, Shinya Goto,et al.World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.Glob Heart.2014,9(4):457-67.
|
[28] |
Bin Wu1, Houwen Lin, Ruoyan Gai Tobe,et al.Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials[J].J Comp Eff Res.2017.
|
[29] |
Caldeira D, Pinto FJ, Ferreira JJ.Dyspnea and reversibility profile of P2Y12 antagonists: systematic review of new antiplatelet drugs[J]. Am J Cardiovasc Drugs,2014,14(4):303-311.
|
[30] |
邵春丽,颜红兵,乔树宾,等.替格瑞洛相关呼吸困难的调查分析[J].中国介入心脏病学杂志.2015,23(2):85-88.
|
[31] |
James S, Budaj A, Aylward P,et al.Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes(PLATO) trial[J].Circulation,2010,122(11):1056-1067.
|